Erin Allman‑Updyke and Erin Welsh

speaker

988 appearances 1 recordings 1 series first heard Aug 2026 last heard 4 Aug

Erin Allman‑Updyke and Erin Welsh’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.

Appearances

newest first · ▶ plays the moment

This Podcast Will Kill You · Ep 218 The Lowdown on Statins · 4 Aug 2026 podcast

But often, with all these different reasons, it was a combination of things that led people to either refuse statins or stop taking them.

Within two years, roughly 40% of people who were taking them for primary prevention and 25% of people on statins for secondary prevention end up stopping the medication.

Yes.

So to say that these negative attitudes towards statins are worrisome, I think is quite an understatement.

It could have serious, even fatal consequences.

So what do we do about it?

The first step is understanding why.

You know, where are these attitudes, these beliefs coming from?

Many of the reasons that people give for not taking or discontinuing statins can be attributed in part to misinformations or negative beliefs promoted across social media.

When statins first came on the market in the late 1980s, the cholesterol-heart disease link had not yet been fully embraced by the general public.

And in fact, there were some highly publicized front-page stories written by vocal deniers

controversy sells consensus doesn't yes and so all of a sudden you go to the doctor your doctor is telling you you should take this drug for your cholesterol but just that morning you read how the cholesterol heart disease link is overblown so that big pharma can rake in the dough and get people on meds for life

Why would you do this, right?

And I get it.

There is some truth to this involvement, especially early drug trials being designed by pharmaceutical companies.

Many researchers in this area hold board positions or receive funding from these companies or have a patent for these drugs.

There are financial ties that are undeniable.

A hundred percent.

And I will say like in today's day and age, not just with pharmaceutical companies, also with radiology companies and imaging companies and genetic testing companies.

Showing 361–380 of 988 · page 19 of 50